Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Employee benefits work for DSM Services USA
Drafted qualified retirement plan documents for DSM Services USA, including summary plan descriptions, summary of material modification, and plan more
Outsourcing for a major credit card and check verification company
Represented a major credit card and check verification company with respect to credit card processing, call centers and back office support to two more
Patent litigation related to estimated arrival times for four major airlines
Successfully represented four major airlines in patent infringement case involving location and estimated time of arrival of vehicles. Although many more
Underwriter's counsel for Keefe Bruyette & Woods in a $122 million public offering
Represented underwriter, Keefe Bruyette & Woods, in the $122 million initial public offering by Territorial Bancorp Inc. more